Skip to main content

Prototype Prescribing Outlier Dashboard for Phoenix (Bnssg) PCN

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all PCNs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given PCN is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all PCN's chemical:subparagraph ratios is provided, with this PCN's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Phoenix (Bnssg) PCN is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Bambuterol hydrochloride 32 Selective beta(2)-agonists 5,748 0.01 0.00 0.00 10.80
Lacosamide 335 Control of epilepsy 8,476 0.04 0.01 0.00 6.54
Trimipramine maleate 66 Tricyclic and related antidepressant drugs 4,937 0.01 0.00 0.00 5.36
Ibuprofen lysine 12 Non-steroidal anti-inflammatory drugs 2,941 0.00 0.00 0.00 4.99
Lanthanum carbonate 10 Phosphate binding agents 16 0.62 0.07 0.11 4.90
Azilsartan medoxomil 4 Angiotensin-II receptor antagonists 4,844 0.00 0.00 0.00 4.81
Diclofenac sodium 4 Ocular diagnostic & peri-operative prepn & photodynamic tt 12 0.33 0.03 0.07 4.56
Podophyllotoxin 10 Preparations for warts and calluses 28 0.36 0.06 0.07 4.52
Other topical corticosteroid preparations 3 Topical corticosteroids 3,020 0.00 0.00 0.00 4.24
Zuclopenthixol hydrochloride 148 Antipsychotic drugs 3,833 0.04 0.01 0.01 4.12

Prescribing where Phoenix (Bnssg) PCN is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Co-amilofruse (Amiloride hydrochloride/frusemide) 10 Potassium sparing diuretics and compounds 50 0.20 0.70 0.19 -2.69
Ciprofloxacin 87 Quinolones 135 0.64 0.86 0.08 -2.58
Alfentanil hydrochloride 0 Opioid analgesics 3 0.00 0.84 0.35 -2.36
    Glycopyrronium bromide 0 Antimuscarinic drugs 2 0.00 0.78 0.36 -2.14
      Timolol and bimatoprost 28 Treatment of glaucoma 1,925 0.01 0.10 0.04 -2.11
      Betamethasone esters 13 Topical corticosteroids 3,020 0.00 0.03 0.01 -2.04
      Tiotropium bromide 225 Antimuscarinic bronchodilators 532 0.42 0.71 0.14 -1.98
      Betahistine hydrochloride 184 Drugs used in nausea and vertigo 1,440 0.13 0.26 0.07 -1.97
      Estradiol with progestogen 421 Oestrogens and Hormone Replacement Therapy 1,722 0.24 0.38 0.07 -1.94
      Glucose blood testing reagents 1,434 Diabetic diagnostic and monitoring agents 1,598 0.90 0.94 0.02 -1.90